Harrow says IHEEZO trial shows 58% lower discomfort than proparacaine after intravitreal injections

• Harrow reported new clinical study results for IHEEZO, an ocular anesthetic gel used during intravitreal injections.
• Findings were announced now, with no indication of a future conference presentation.
• Patients in a bilateral-eye study reported less post-injection discomfort with IHEEZO versus a commonly used legacy anesthetic.
• Benefit was consistent across multiple post-procedure time checks, strongest soon after injection, supporting broader adoption in high-volume retina practices.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harrow Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608200700PRIMZONEFULLFEED9813296) on August 20, 2026, and is solely responsible for the information contained therein.